Business

Ola confirms plans to enter Australia market

Ola confirms plans to enter Australia market

He said Ola has a "strong focus on driver-partners and the community at large", and that the company looks forward to "contributing to a healthy mobility ecosystem in Australia". The worldwide beginning of Ola comes months after the conclusion of its anti-Uber alliance with Didi, Lyft, and Grab. Ola had raised $1.1 billion in funding from Tencent, Softbank in October 2017, its largest funding round since 2015 when it raised $500 million.


German Automakers Exposed Humans And Monkeys To Car Exhaust

German Automakers Exposed Humans And Monkeys To Car Exhaust

The revelations coincide with the German automotive industry beginning to recover from long-standing " dieselgate " and "cartel" scandals, posting several record annual earnings figures in 2017. It was commissioned by the European Research Group on Environment and Health in the Transport Sector (EUGT) - a group funded by German carmakers Volkswagen, BMW and Daimler.


Health Dept. investigating improper handling of raw meat at California supermarket

Health Dept. investigating improper handling of raw meat at California supermarket

Loretta Seto couldn't believe what she was seeing at a San Jose supermarket Thursday, so she took our her cellphone and snapped photos of the surreal scene. Now authorities are investigating the unsanitary delivery to 99 Ranch in San Jose after receiving several complaints. "We are thoroughly investigating the incident", Moon said.


ICBC posts almost a billion in net losses

ICBC posts almost a billion in net losses

The insurer says the loss "is further evidence of the growing financial pressures we are under from the rapid increase in the number of crashes occurring across B.C., the surge in claims and the massive growth in the costs of those claims".


France's Sanofi buys Ablynx for US$4.8 billion in biotech M&A boom

France's Sanofi buys Ablynx for US$4.8 billion in biotech M&A boom

Last week, Sanofi agreed to buy USA haemophilia specialist Bioverativ for $11.6bn (£8.2bn), and US-based Calgene also recently said it would buy cancer specialist Juno Therapeutics for $9bn. Sanofi is already one of Ablynx's big pharma partners, after striking a deal in July 2017 to find new treatments for inflammatory diseases. Ablynx's most-advanced product in development is caplacizumab (anti-vWF Nanobody), a wholly-owned development program for the treatment of ...